Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!()

The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Alan A., Habiballah, Saddiq B., Platt, Craig D., Geha, Raif S., Chou, Janet S., McDonald, Douglas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211658/
https://www.ncbi.nlm.nih.gov/pubmed/32418917
http://dx.doi.org/10.1016/j.clim.2020.108459
Descripción
Sumario:The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.

Ejemplares similares